HUBBARD R, WALD G
J Gen Physiol. 1952 Nov;36(2):269-315. doi: 10.1085/jgp.36.2.269.
Vitamin A and retinene, the carotenoid precursors of rhodopsin, occur in a variety of molecular shapes, cis-trans isomers of one another. For the synthesis of rhodopsin a specific cis isomer of vitamin A is needed. Ordinary crystalline vitamin A, as also the commercial synthetic product, both primarily all-trans, are ineffective. The main site of isomer specificity is the coupling of retinene with opsin. It is this reaction that requires a specific cis isomer of retinene. The oxidation of vitamin A to retinene by the alcohol dehydrogenase-cozymase system displays only a low degree of isomer specificity. Five isomers of retinene have been isolated in crystalline condition: all-trans; three apparently mono-cis forms, neoretinenes a and b and isoretinene a; and one apparently di-cis isomer, isoretinene b. Neoretinenes a and b were first isolated in our laboratory, and isoretinenes a and b in the Organic Research Laboratory of Distillation Products Industries. Each of these substances is converted to an equilibrium mixture of stereoisomers on simple exposure to light. For this reaction, light is required which retinene can absorb; i.e., blue, violet, or ultraviolet light. Yellow, orange, or red light has little effect. The single geometrical isomers of retinene must therefore be protected from low wave length radiation if their isomerization is to be avoided. By incubation with opsin in the dark, the capacity of each of the retinene isomers to synthesize rhodopsin was examined. All-trans retinene and neoretinene a are inactive. Neoretinene b yields rhodopsin indistinguishable from that extracted from the dark-adapted retina (lambda(max.) 500 mmicro). Isoretinene a yields a similar light-sensitive pigment, isorhodopsin, the absorption spectrum of which is displaced toward shorter wave lengths (lambda(max.) 487 mmicro). Isoretinene b appears to be inactive, but isomerizes preferentially to isoretinene a, which in the presence of opsin is removed to form isorhodopsin before the isomerization can go further. The synthesis of rhodopsin in solution follows the course of a bimolecular reaction, as though one molecule of neoretinene b combines with one of opsin. The synthesis of isorhodopsin displays similar kinetics. The bleaching of rhodopsin, whether by chemical means or by exposure to yellow or orange (i.e., non-isomerizing) light, yields primarily or exclusively all-trans retinene. The same appears to be true of isorhodopsin. The process of bleaching is therefore intrinsically irreversible. The all-trans retinene which results must be isomerized to active configurations before rhodopsin or isorhodopsin can be regenerated. A cycle of isomerization is therefore an integral part of the rhodopsin system. The all-trans retinene which emerges from the bleaching of rhodopsin must be isomerized to neoretinene b before it can go back; or if first reduced to all-trans vitamin A, this must be isomerized to neovitamin Ab before it can regenerate rhodopsin. The retina obtains new supplies of the neo-b isomer: (a) by the isomerization of all-trans retinene in the eye by blue or violet light; (b) by exchanging all-trans vitamin A for new neovitamin Ab from the blood circulation; and (c) the eye tissues may contain enzymes which catalyze the isomerization of retinene and vitamin A in situ. When the all-trans retinene which results from bleaching rhodopsin in orange or yellow light is exposed to blue or violet light, its isomerization is accompanied by a fall in extinction and a shift of absorption spectrum about 5 mmicro toward shorter wave lengths. This is a second photochemical step in the bleaching of rhodopsin. It converts the inactive, all-trans isomer of retinene into a mixture of isomers, from which mixtures of rhodopsin and isorhodopsin can be regenerated. Isorhodopsin, however, is an artefact. There is no evidence that it occurs in the retina; nor has isovitamin Aa or b yet been identified in vivo. In rhodopsin and isorhodopsin, the prosthetic groups appear to retain the cis configurations characteristic of their retinene precursors. In accord with this view, the beta-bands in the absorption spectra of both pigments appear to be cis peaks. The conversion to the all-trans configuration occurs during the process of bleaching. The possibility is discussed that rhodopsin may represent a halochromic complex of a retinyl ion with opsin. The increased resonance associated with the ionic state of retinene might then be responsible both for the color of rhodopsin and for the tendency of retinene to assume the all-trans configuration on its release from the complex. A distinction must be made between the immediate precursor of rhodopsin, neovitamin Ab, and the vitamin A which must be fed in order that rhodopsin be synthesized in vivo. Since vitamin A isomerizes in the body, it is probable that any geometrical isomer can fulfill all the nutritional needs for this vitamin.
维生素A和视黄醛是视紫红质的类胡萝卜素前体,它们以多种分子形式存在,互为顺反异构体。视紫红质的合成需要特定顺式异构体的维生素A。普通结晶维生素A以及市售合成产品主要都是全反式的,均无活性。异构体特异性的主要位点在于视黄醛与视蛋白的偶联。正是这个反应需要视黄醛的特定顺式异构体。通过醇脱氢酶 - 辅酶系统将维生素A氧化为视黄醛的过程仅表现出较低程度的异构体特异性。视黄醛的五种异构体已在结晶状态下分离出来:全反式;三种明显的单顺式形式,新视黄醛a和b以及异视黄醛a;还有一种明显的双顺式异构体,异视黄醛b。新视黄醛a和b首先在我们实验室中分离出来,异视黄醛a和b则在蒸馏产品工业有机研究实验室中分离出来。这些物质中的每一种在简单暴露于光时都会转化为立体异构体的平衡混合物。对于这个反应,需要视黄醛能够吸收的光,即蓝光、紫光或紫外线。黄色、橙色或红色光几乎没有影响。因此,如果要避免视黄醛单一几何异构体的异构化,就必须保护它们免受低波长辐射。通过在黑暗中与视蛋白一起孵育,检测了每种视黄醛异构体合成视紫红质的能力。全反式视黄醛和新视黄醛a无活性。新视黄醛b产生的视紫红质与从暗适应视网膜中提取的视紫红质无法区分(最大吸收波长500毫微米)。异视黄醛a产生一种类似的光敏色素,异视紫红质,其吸收光谱向较短波长移动(最大吸收波长487毫微米)。异视黄醛b似乎无活性,但优先异构化为异视黄醛a,在存在视蛋白的情况下,异视黄醛a在异构化进一步进行之前被去除以形成异视紫红质。溶液中视紫红质的合成遵循双分子反应过程,就好像一个新视黄醛b分子与一个视蛋白分子结合。异视紫红质的合成显示出类似的动力学。视紫红质的漂白,无论是通过化学方法还是通过暴露于黄色或橙色(即非异构化)光,主要或仅产生全反式视黄醛。异视紫红质似乎也是如此。因此,漂白过程本质上是不可逆的。产生的全反式视黄醛在视紫红质或异视紫红质再生之前必须异构化为活性构型。因此,异构化循环是视紫红质系统的一个组成部分。视紫红质漂白产生的全反式视黄醛在返回之前必须异构化为新视黄醛b;或者如果首先还原为全反式维生素A,则必须异构化为新维生素Ab才能再生视紫红质。视网膜通过以下方式获得新的新b异构体供应:(a)通过眼睛中蓝光或紫光对视黄醛全反式异构体的异构化;(b)通过将全反式维生素A与血液循环中的新维生素Ab交换;以及(c)眼组织可能含有催化视黄醛和维生素A原位异构化的酶。当在橙色或黄色光下漂白视紫红质产生的全反式视黄醛暴露于蓝光或紫光时,其异构化伴随着消光的下降和吸收光谱向较短波长移动约5毫微米。这是视紫红质漂白中的第二个光化学步骤。它将无活性的全反式视黄醛异构体转化为异构体混合物,从中可以再生视紫红质和异视紫红质的混合物。然而,异视紫红质是一种人工产物。没有证据表明它存在于视网膜中;体内也尚未鉴定出异维生素Aa或b。在视紫红质和异视紫红质中,辅基似乎保留了其视黄醛前体特有的顺式构型。与此观点一致,两种色素吸收光谱中的β带似乎都是顺式峰。向全反式构型的转化发生在漂白过程中。有人讨论了视紫红质可能代表视黄基离子与视蛋白的加色络合物的可能性。与视黄醛离子状态相关的增强共振可能既对视紫红质的颜色负责,又对视黄醛从络合物释放时呈现全反式构型的趋势负责。必须区分视紫红质的直接前体新维生素Ab和为了在体内合成视紫红质而必须摄入的维生素A。由于维生素A在体内异构化,任何几何异构体都可能满足该维生素的所有营养需求。